Sasha Khursheed Said
Sasha K. Said is a founding member of the LTP investment team where she sources and structures deals; provides representation for LTP on the Board of Directors, in addition to providing strategic and tactical support to portfolio companies. She has 12 years of investing experience across asset classes, 4 of which were spent with Waypoint Capital, a multi-billion dollar biotech family office where she helped launch a $2B life science fund, Gurnet Point Capital, now managed by Chris Viehbacher, and built the corporate venture group with a strategy in digital health. Prior to Waypoint, Sasha was a Global Long/Short Public Equity and Private Equity Analyst at Water Asset Management, a global hedge fund in New York City.
Sasha serves as a Board Observer for LTP on the Boards of Vera Whole Health and Health Catalyst and was instrumental in helping Health Catalyst launch its new life sciences division. She is also co-Founder and Chairman of The Pharma Digital Health Roundtable whose mission is to convene senior level pharmaceutical and medtech leaders across functions and therapeutics areas bi-monthly to foster the life science industry’s excitement to take advantage of digital solutions enabling life saving therapies faster and cheaper with better outcomes. Sasha is also Founder of Breaking7% (B7), a group of 122 women (51% senior/ 49% junior) in deal making roles in Boston who meet monthly to discuss deal flow and network. She is also an Advisor to Pulse companies, Massachusetts’ digital health accelerator.